Live
- Three persons admitted to hospital for diarrhea treatment
- First Star Outside Milky Way Captured: WOH G64 is 2,000 Times Larger Than the Sun
- Sikkim govt to constitute state Niti Ayog: CM Tamang
- CBI books Rajasthan narcotics inspector for Rs 3 lakh bribe
- Rajasthan bypolls: A tough contest between BJP and Congress
- Albania joins SEPA, paving way for EU integration
- Japanese government approves 250-billion USD economic package to ease price pain
- Six pharma companies to set up their units in Telangana
- The Unstable Events of a 17-Wicket Day in Perth: India vs Australia
- Dutch FM's Israel trip cancelled after Netanyahu's arrest warrant
FDA issues 9 observations to Natco's Kothur unit
Natco Pharma Limited on Thursday said the US Food and Drug Administration has issued nine observations under Form 483 for its formulation facility in Kothur Village, near here.
Hyderabad: Natco Pharma Limited on Thursday said the US Food and Drug Administration has issued nine observations under Form 483 for its formulation facility in Kothur Village, near here. The city-based drug-maker said, the inspection was conducted between May 30 and June 5 and the company would provide due justifications and corrective action plan within the next 15 working days to address the USFDA observations.
At the end of the inspection, the facility received nine observations, with no repeat observations and mostly procedural in nature. The company believes that none of the observations were related to data integrity and that all of the observations can be addressed within a short period of time, it said. Visual inspection of products carried out as part of investigation was not properly documented, the FDA said in one of the observations.
